The group’s research is focused on assessing risk factors for the development and progression of age-related macular degeneration and other retinal diseases, treatment outcomes (patient and physician reported) and the development of novel outcome measures, including structural, functional and patient-reported assessments, all with a focus on retinal diseases. For this we apply epidemiological as well as clinical research methodology including qualitative research methods related to the development of patient reported outcomes as well as for patient participation. In order to better understand the value of high-resolution retinal imaging in all of this, we collaborate closely with AI experts to develop automated image analysis solutions applicable to research questions in ophthalmic epidemiology.